Back to RTW INVESTMENTS, LP

RARE
Showing 8 of 18 quarters

Position history for RTW INVESTMENTS, LP's holdings in ULTRAGENYX PHARMACEUTICAL IN

RTW INVESTMENTS, LP holds 3.6M shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $76.4M as of 2026-Q1. The position was increased (+21.6% shares). RARE represents 0.8% of RTW INVESTMENTS, LP's portfolio.

Current Value

$76.4M

Current Shares

3.6M

Total Value Change

-$57.5M

Total Shares Change

+388,868

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
3.6M
+21.6%
$76.4M0.8%$22.07
50
2025-Q4
Decreased
3M
-7.9%
$69M0.7%$22.78
0
2025-Q3
Increased
3.3M
+90.8%
$98M1.2%$30.36
74
2025-Q2
Unchanged
1.7M
0.0%
$62.1M0.9%$36.52
0
2025-Q1
Decreased
1.7M
-13.2%
$61.8M0.9%$37.82
0
2024-Q4
Unchanged
2M
0.0%
$82.8M1.3%$42.27
0
2024-Q3
Decreased
2M
-39.6%
$109.3M1.6%$54.43
0
2024-Q2
Decreased
3.3M
-54.0%
$134M2.1%$41.10
0

Other major holders of RARE: Capital Research Global Investors, Capital International Investors, FEDERATED HERMES, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used